Carotid arterial stenting (CAS) is a minimally invasive endovascular interventional procedure that can potentially offer the same advantage as surgery (carotid endarterectomy).
ACAS and ACST could show a minor preventive effect of carotid surgery in carotid stenosis between 60% and 99%. A refined assessment of risk according to stenosis grade could not be made because of various methodological problems. In ACAS, absolute risk reduction of stroke and/or death was 5.9% and in ACST 5.4%, in a time frame of 5 years. CarotidArteryStenosis Executive Committee for the Asymptomatic Carotid Atherosclerosis Study Objective. P=m- To determine whetherthe addition of carotid endarterectomy to. What ACAS authors failed to emphasize is that screening truly asymptomatic patients with noninvasive tests, performing carotid angiography on all patients with positive tests, and finally performing carotid endarterectomy on patients with greater than 60% stenosis of any internal carotid artery will never prevent strokes in the long run.
Indications for carotid stenting are evolving with endarterectomy trials that evaluate the carotid stenosis cutoff values for treatment. Currently, the indications include:
Operator skills and experience have a profound impact on patient outcomes following CAS. One systematic review and meta-analysis of the literature found Carotid Endarectomy (CEA) to be superior to CAS in freedom from stroke/death within 30 days of treatment, with the incidence of stroke/death within 30 days of treatment was 4.7% for CAS and 3.5% for CEA 8.